Episode 64
Biotech Hangout
00:00
The SVB Meltdown: Bruce Leerink Back in the Fold
It's great to have him back in the fold. I think they're a fine firm. They offered a lot to the industry and obviously we all wish them well. Great. We have an audience comment from Handel snack biotech. Love to hear any feedback on pricing for accelerated approval, ultra rare disease drugs. Does anybody else want to comment on accelerated approval,. ultra rare and pricing in general? Chris Mike, Jeff Reese, one is that some of the inputs around that have to do with alternative therapies or what's going on there.
Transcript
Play full episode
